Bay Street News, 2024

HOOKIPA announces alignment with FDA on pivotal trial design and protocol for HB-200 in combination with pembrolizumab HB-200 program receives […]

TORONTO and PHILADELPHIA, April 10, 2024 (GLOBE NEWSWIRE) — Leading diversified professional services and investment management firm Colliers (NASDAQ and […]

NEW YORK, April 10, 2024 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel […]

Extended the Strategic Collaboration with Gilead Sciences Extended the Strategic Collaboration with Sanofi to Develop Novel Orally Available Targeted Protein […]

Singapore, April 10, 2024 (GLOBE NEWSWIRE) — Nova Vision Acquisition Corp. (NASDAQ: NOVV, the “Company”), a special purpose acquisition company, […]

PRINCETON, N.J., April 10, 2024 (GLOBE NEWSWIRE) — Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) plans to report First Quarter 2024 […]

PARIS, April 10, 2024 (GLOBE NEWSWIRE) — Constellium SE (NYSE: CSTM) announced today the signing of a partnership agreement with […]

SINGAPORE, April 10, 2024 (GLOBE NEWSWIRE) — Multi Ways Holdings Limited (“Multi Ways” or the “Company”) (NYSE American: MWG), a […]

TORONTO, April 10, 2024 (GLOBE NEWSWIRE) — Xtract One Technologies (TSX: XTRA)(“Xtract One” or the “Company”), a leading technology-driven threat […]

MONTRÉAL, April 10, 2024 (GLOBE NEWSWIRE) — The Annual and Special Meeting of Shareholders of Stella-Jones Inc. will be held […]